Benzinga's M&A Chatter for Tuesday September 11, 2012

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday September 11, 2012: Mellanox Reports B‌eing Approached Multiple Times by Potential Buyers The Offers:
Mellanox Technologies MLNX reported Tuesday that the company has been approached multiple times by potential buyers, according to CEO Eyal Waldman speaking to Reuters. Oracle ORCL currently has a 10% stake in Mellanox, Fidelity owns 14%. Mellanox Technologies closed at $102.41 Tuesday, a gain of 0.75% on 2.5 time saverage volume. Monster Worldwide Says Still in Sale Process The Rumor:
A Monster Worldwide MWW spokesperson told Benzinga Tuesday the company is still in talks to sell itself. There was chatter last week that the company was in the final stages of a bidding process that might include Microsoft MSFT, Oracle ORCL, News Corp NWSA and Salesforce.com CRM. There was a sharp selloff in Monster shares at around 10:45am. The Monster spokesperson had no news to account for the move. Monster Worldwide closed at $7.91 Tuesday, a loss of 2.94% on 2.5 times average volume. Blog Post Says Pfizer Could Buy Amarin The Rumor:
Pfizer PFE could buy Amarin AMRN, according to the blog Buyvascepa.com. Spokespersons for Amarin and Pfizer were not available for comment. Amarin closed at $13.56 Tuesday, a loss of 5.90% on 1.5 times average volume.